Brief: Onxeo To Present Next-Generation PARP Inhibitor At European ESMO-TAT Congress 2020
Feb 27 (Reuters) - ONXEO SA C4X.PA :
* ONXEO TO PRESENT NEXT-GENERATION PARP INHIBITOR, OX401, AT
THE
EUROPEAN ESMO-TAT CONGRESS 2020
Source text for Eikon: ID:nBw2DhkKBa
Further company coverage: C4X.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Valerio Therapeutics SA
See all newsBrief: Valerio Therapeutics To Buy Etherna Immunotherapies For €30 Mln
Brief: Valerio Therapeutics Signs Development Collaboration With Abivax
Brief: Valerio Therapeutics Enters Into Collaboration & Exclusive License With Seed-Stage Biotech Co
Brief: Onxeo Changes Its Name And Becomes Valerio Therapeutics
Brief: Onxeo H1 Net Loss Widens To EUR 11.5 Mln